Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $3.17 million. The enterprise value is -$1.20 million.

Market Cap	3.17M
Enterprise Value	-1.20M

Important Dates

The next estimated earnings date is Friday, August 7, 2026, after market close.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

CLDI has 19.46 million shares outstanding. The number of shares has increased by 445.70% in one year.

Current Share Class	19.31M
Shares Outstanding	19.46M
Shares Change (YoY)	+445.70%
Shares Change (QoQ)	+44.73%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	10.58%
Float	19.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.46.

Current Ratio	1.92
Quick Ratio	1.73
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-70.93

Financial Efficiency

Return on equity (ROE) is -312.39% and return on invested capital (ROIC) is -126.10%.

Return on Equity (ROE)	-312.39%
Return on Assets (ROA)	-98.18%
Return on Invested Capital (ROIC)	-126.10%
Return on Capital Employed (ROCE)	-336.49%
Weighted Average Cost of Capital (WACC)	10.67%
Revenue Per Employee	n/a
Profits Per Employee	-$862,414
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $16,000 in taxes.

Income Tax	16,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.08% in the last 52 weeks. The beta is 1.31, so CLDI's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-94.08%
50-Day Moving Average	0.19
200-Day Moving Average	0.88
Relative Strength Index (RSI)	44.47
Average Volume (20 Days)	4,877,901

Short Selling Information

The latest short interest is 1.22 million, so 6.25% of the outstanding shares have been sold short.

Short Interest	1.22M
Short Previous Month	670,614
Short % of Shares Out	6.25%
Short % of Float	6.41%
Short Ratio (days to cover)	0.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.37M
Pretax Income	-19.09M
Net Income	-25.01M
EBITDA	-17.68M
EBIT	-19.37M
Earnings Per Share (EPS)	-$3.96

Full Income Statement

Balance Sheet

The company has $6.63 million in cash and $2.26 million in debt, giving a net cash position of $4.37 million or $0.22 per share.

Cash & Cash Equivalents	6.63M
Total Debt	2.26M
Net Cash	4.37M
Net Cash Per Share	$0.22
Equity (Book Value)	4.94M
Book Value Per Share	0.41
Working Capital	3.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.28 million and capital expenditures -$118,000, giving a free cash flow of -$18.40 million.

Operating Cash Flow	-18.28M
Capital Expenditures	-118,000
Depreciation & Amortization	1.68M
Net Borrowing	-867,000
Free Cash Flow	-18.40M
FCF Per Share	-$0.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-445.70%
Shareholder Yield	-445.70%
Earnings Yield	-787.92%
FCF Yield	-579.55%

Analyst Forecast

The average price target for CLDI is $120.00, which is 73,474.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$120.00
Price Target Difference	73,474.49%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:12.

Last Split Date	Aug 5, 2025
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1